...
首页> 外文期刊>Cureus. >Bilateral Popliteal Vein Thrombosis, Acute Pulmonary Embolism and Mild COVID-19
【24h】

Bilateral Popliteal Vein Thrombosis, Acute Pulmonary Embolism and Mild COVID-19

机译:双侧popliteal静脉血栓形成,急性肺栓塞和轻度covid-19

获取原文

摘要

In 2020, the coronavirus disease 2019 (COVID-19) has become a global health disaster. Patients with COVID-19 have variable clinical features and unpredictable prognoses; the infectious complication may occur in many organs, causing a broad spectrum of symptoms and severity. Pulmonary embolism (PE) is a fatal urgent complication, which may occur following a severe infection. While the pathogenesis of PE in COVID-19 remains uncertain, it has mainly occurred in patients with severe disease. PE, as an initial presentation of COVID-19 in a patient with mild diseases, is rare and understudied. Here, we describe a young woman with mild COVID-19 illness and no significant risk factors for PE, except obesity, but had developed bilateral popliteal vein thrombosis and submassive PE. Our case emphasizes that thrombotic complications can occur in any COVID-19 patients regardless of the disease severity, questioning the role of preventive anticoagulants in mild COVID-19 cases with certain risk factors.
机译:2020年,2019年冠状病毒疾病(Covid-19)已成为全球卫生灾难。 Covid-19患者具有可变的临床特征和不可预测的预测;感染性并发症可能发生在许多器官中,导致广泛的症状和严重程度。肺栓塞(PE)是一种致命的紧急并发症,可能在严重感染后发生。虽然Covid-19中PE的发病机制仍然不确定,但它主要发生在严重疾病的患者中。作为患有轻度疾病的患者的Covid-19的初步呈现,是罕见的和解读的。在这里,我们描述了一个轻度Covid-19疾病的年轻女性,除了肥胖之外,PE没有显着的风险因素,但已经开发出双边popliteal静脉血栓形成和潜水量。我们的案例强调,无论疾病严重程度如何,任何Covid-19患者都会发生血栓形成并发症,质疑预防性抗凝血剂在轻度Covid-19患者中具有一定的风险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号